PGP and non-small cell lung carcinoma: By activating MAPK and inhibiting the expression of P-gp and MDR1, RA can inhibit the growth and cell colony formation, induce apoptosis and cell cycle arrest of non-small cell lung cancer (NSCLC) in a dose-dependent manner, in addition to elevating the sensitivity of cisplatin-resistant cells [263].